Summary
Fibroblast-like synovial cells, isolated from intact joints of non-arthritic human donors and from explants of rheumatoid and non-rheumatoid synovial tissue, released prostacyclin (PGI2) when incubated in conditioned medium from human peripheral blood mononuclear cells (MCCM). The effect of MCCM on the rate of PGI2 synthesis (measured by radioimmunoassay as the stable product, 6-keto-PGF1 α) was clearly established within 2 h and appeared to require RNA and protein synthesis as judged by inhibition with actinomycin D and cycloheximide, respectively. Low concentrations of dexamethasone suppressed the increase in PGI2 levels. Prostaglandin E2 (PGE2) levels were also raised by the MCCM and reduced by dexamethasone. All-trans retinoic acid did not stimulate the levels of either prostanoid. These findings offer an explanation for some of the inflammatory events occurring in rheumatoid lesions.
Similar content being viewed by others
References
Higgs GA, Moncada S, Vane JR (1980) The mode of action of anti-inflammatory drugs which prevent the peroxidation of arachidonic acid. Clin Rheum Dis 61:675–693
Trang LE, Granstrom E, Lovgren O (1977) Levels of prostaglandins F2 α and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 6:151–154
Brodie MJ, Hensby CN, Parke A, Gordon D (1980) Is prostacyclin the major pro-inflammatory prostanoid in joint fluid? Life Sci 27:603–608
Robinson DR, Smith H, McGuire MB, Levine L (1975) Prostaglandin synthesis by rheumatoid synovium and its stimulation by colchicine. Prostaglandins 10:67–85
Salmon JA, Higgs GA, Vane JR, Bitensky K, Chayen J, Henderson B, Cashman B (1983) Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and non-rheumatoid synovial lining in nonproliferative organ culture. Ann Rheum Dis 42:36–39
MacIntyre DE, Pearson JD, Gordon JL (1978) Localisation and stimulation of prostacyclin production in vascular cells. Nature 271:549–551
Hammarstrom S, Falardeav P (1977) Resolution of prostaglandin endoperoxide synthesis and thromboxane synthesis of human platelets. Proc Natl Acad Sci USA 74:3691–3695
Gemsa D, Leser H-G, Seitz M, Deimann W, Barlin E (1982) Membrane perturbation and stimulation of arachidonic acid metabolism. Mol Immunol 19:1287–1296
Castor CW, Lewis RB (1975) Connective tissue activation. Current studies of the process and its mediators. Scand J Rheumatol 5:41–54
McGuire MKB, Meats JE, Ebsworth NM, Harvey L, Murphy G, Russell RGG, Reynolds JJ (1982) Properties of rheumatoid and normal synovial tissue in vitro and cells derived from them. Production of prostaglandins and collagenase in response to factors derived from cultured blood mononuclear cells and from synovium. Rheumatol Int 2:113–120
Robinson DR, Bastian D, Hamer PJ, Pichiarallo DM, Stephenson ML (1981) Mechanism of stimulation of prostaglandin synthesis by a factor from rheumatoid synovial tissue. Proc Natl Acad Sci USA 78:5160–5164
Hamilton JA, Slywka J (1981) Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants. J Immunol 126:851–855
Dayer J-M, Breard J, Chess L, Krane SM (1979) Participation of monocyte-macrophages in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest 64:1386–1392
Golds EE, Ciosek CP Jr, Hamilton JA (1983) Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells. Arthritis Rheum 26:15–21
Clarris BJ, Hamilton JA (1985) Peripheral blood mononuclear cells stimulate n-acetyl-β-glucosaminidase levels of human synovial fibroblast-like cells. Rheumatol Int 5:55–60
Hamilton JA (1982) Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids. Arthritis Rheum 25:432–440
Hamilton JA (1983) Synovial cell activation. Studies on the mechanism of action of synovial activator activity. J Rheumatol 10:872–880
Ropes MW (1959) Diagnostic criteria for rheumatoid arthritis: 1958 revision. Ann Rheum Dis 18:48–53
Fraser JRE, McCall JF (1965) Culture of synovial cells in vitro. Ann Rheum Dis 38:287–294
Levine L, Gutsenez-Cernosik RM, Vunakis H Van (1971) Specificities of prostaglandins B1, F1 and F2 antigen-antibody reactions. J Biol Chem 246:6782–6785
Nolan RD, Dusting GJ, Martin TJ (1981) Phospholipase inhibition and the mechanism of angiotensin-induced prostacyclin release from rat mesenteric vasculature. Biochem Pharmacol 30:2121–2125
Hamilton JA, Bootes AJ, Phillips PE, Slywka J (1981) Human synovial fibroblast plasminogen activator: modulation of enzyme activity by anti-inflammatory steroids. Arthritis Rheum 24:1296–1303
McGuire MKB, Meats JE, Russell RGG (1980) Cell-cell interactions in the rheumatoid joint. Agents Actions 10:486–490
Barland P, Novikoff AB, Hamerman D (1962) Electron microscopy of the human synovial membrane. J Cell Biol 14:207–220
Hamilton JA (1982) Plasminogen activator activity of rheumatoid and non-rheumatoid synovial fibroblasts. J Rheumatol 9:834–842
Clarris BJ, Malcolm LP (1983) Effects of prostaglandins E1, E2 and F2 α on n-acetyl-β-glucosaminidase activities of human synovial cells in culture. Ann Rheum Dis 42:187–191
Werb Z, Mainardi CL, Vater CA, Harris ED Jr (1977) Endogenous activation of latent collagenase by rheumatoid synovial cells: evidence for a role for plasminogen activator. N Engl J Med 296:1017–1023
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hamilton, J.A., Clarris, B.J., Fraser, J.R.E. et al. Peripheral blood mononuclear cells stimulate prostacyclin levels of human synovial fibroblast-like cells. Rheumatol Int 5, 121–125 (1985). https://doi.org/10.1007/BF00541331
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00541331